financetom
Business
financetom
/
Business
/
F5 Fiscal Q3 Non-GAAP Earnings Increase, Revenue Declines; Fiscal Year Guidance Lifted -- Shares Surge After Hours
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
F5 Fiscal Q3 Non-GAAP Earnings Increase, Revenue Declines; Fiscal Year Guidance Lifted -- Shares Surge After Hours
Jul 29, 2024 2:33 PM

05:07 PM EDT, 07/29/2024 (MT Newswires) -- F5 (FFIV) reported fiscal Q3 non-GAAP earnings late Monday of $3.36 per diluted share, up from $3.21 a year earlier.

Analysts polled by Capital IQ expected $2.97.

Revenue for the quarter ended June 30 was $695.5 million, down from $702.6 million a year earlier.

Analysts polled by Capital IQ expected $686 million.

The company said it expects fiscal Q4 non-GAAP earnings of $3.38 to $3.50 per diluted share on revenue of $720 million to $740 million. Analysts polled by Capital IQ expect $3.33 and $717 million, respectively.

F5 said it now expects fiscal year 2024 revenue toward the top end of its prior expectations, at about $2.8 billion, or roughly flat with last year. The company previously expected a growth range of flat to down 2%. Analysts polled by Capital IQ expect $2.78 billion.

The company also now estimates non-GAAP earnings per share for fiscal 2024 to grow about 12% year over year. The company previously issued a guidance of 7% to 9% growth. Analysts polled by Capital IQ expect $12.69.

Shares of the company jumped past 14% in after-hours activity.

Price: 203.00, Change: +25.41, Percent Change: +14.31

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Atara Biotherapeutics Says Tab-Cel Biologics License Application Gets FDA Priority Review
Atara Biotherapeutics Says Tab-Cel Biologics License Application Gets FDA Priority Review
Jul 17, 2024
10:51 AM EDT, 07/17/2024 (MT Newswires) -- Atara Biotherapeutics ( ATRA ) said Wednesday the US Food and Drug Administration has accepted and granted priority review to the company's biologics license application for tabelecleucel, or tab-cel, with a target action date of Jan. 15, 2025. With FDA's acceptance of the biologics license application, Atara said it is set to receive...
Sypris Solutions Unit Gets Long-Term Contract Extension With Truck Manufacturer
Sypris Solutions Unit Gets Long-Term Contract Extension With Truck Manufacturer
Jul 17, 2024
10:48 AM EDT, 07/17/2024 (MT Newswires) -- Sypris Solutions' ( SYPR ) Sypris Technologies unit said Wednesday it has signed a long-term extension to its current supply agreement with a major unnamed commercial vehicle maker. Under the agreement, Sypris will keep providing Ultra axle shafts for use in the assemblies of the client's branded drive axles for medium and heavy-duty...
China tests AI companies' language models to create socialist AI, FT reports
China tests AI companies' language models to create socialist AI, FT reports
Jul 17, 2024
July 17 (Reuters) - Chinese government officials are testing artificial intelligence companies' large language models to ensure their systems embody core socialist values, the Financial Times reported on Wednesday. The Cyberspace Administration of China (CAC) has forced large tech companies and AI start-ups including ByteDance, Alibaba ( BABA ) , Moonshot and 01.AI to take part in a mandatory government...
Boeing Workers in Washington State to Vote on Strike Authorization Amid Wage Talks
Boeing Workers in Washington State to Vote on Strike Authorization Amid Wage Talks
Jul 17, 2024
10:53 AM EDT, 07/17/2024 (MT Newswires) -- Boeing's ( BA ) Washington state factory workers will vote Wednesday on granting their union authority to strike if a new contract isn't in place by Sept. 12 when the current one expires, the aircraft manufacturer said. Up to 30,000 employees, responsible for crafting Boeing's ( BA ) 737 MAX and other aircraft,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved